openPR Logo
Press release

Flu Vaccine Market Driven By Public Health Initiatives 2025-2033 | Most Leading Companies - AstraZeneca, Sanofi, CSL, Serum Institute of India Pvt. Ltd, Viatris Inc., Hualan Biological Engineering Inc

05-12-2025 08:16 AM CET | Health & Medicine

Press release from: DataM Intelligence 4 Market Research LLP

Flu Vaccine Market

Flu Vaccine Market

The Global Flu Vaccine Market reached US$ 5.70 billion in 2024 and is expected to reach US$ 10.74 billion by 2033, growing at a CAGR of 7.3% during the forecast period 2025-2033.

Flu Vaccine Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Request a Free Sample PDF of This Report (Corporate Email IDs Receive Priority Service): https://datamintelligence.com/download-sample/flu-vaccine-market?kb

A flu vaccine is an immunization that protects against influenza viruses, typically updated annually to match circulating strains. It reduces the risk of flu-related illness, hospitalization, and death, especially in vulnerable populations.

List of the Key Players in the Flu Vaccine Market:

AstraZeneca, Sanofi, CSL, Serum Institute of India Pvt. Ltd, Viatris Inc., Hualan Biological Engineering Inc., Sinovac Biotech Ltd., GSK Plc, Pfizer Inc., and CureVac N.V., among others.

Industry Development:

In September 2023, the NIH initiated a Phase I trial for a broad-spectrum "universal" flu vaccine, while Pfizer advanced its vaccine efforts with the launch of a Phase 3 trial for its quadrivalent modified RNA (modRNA) influenza vaccine, highlighting continuous innovation in flu prevention.

In October 2023, Mylab and the Serum Institute of India (SII) introduced Nasovac S4, the country's first needle-free nasal influenza vaccine, covering four virus strains per WHO guidelines. Similarly, Cadila Pharmaceuticals launched Cadiflu Tetra, a next-generation quadrivalent flu vaccine, in the same month.

These cutting-edge developments are expected to enhance awareness among healthcare professionals and the public, fueling demand for effective immunization and propelling market growth in the coming years.

Research Process:

Both primary and secondary data sources have been used in the global Flu Vaccine Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/flu-vaccine-market?kb

Segment Covered in the Flu Vaccine Market:

By Type: Whole virus vaccines, Split virus vaccines, Subunit vaccines, Live attenuated virus vaccines

By Distribution Channel: Institutional, Hospitals, Community Clinics, Public health agencies, Workplaces, Retails, Retail pharmacy, Mail order pharmacy

By Application: For Children below 3 years, For Adults and Children over 3 years

Regional Analysis for Flu Vaccine Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/flu-vaccine-market?kb

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Flu Vaccine market?

➠ Who are the leading manufacturers in the global Flu Vaccine industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Flu Vaccine industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Flu Vaccine market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Stay informed with the latest industry insights-start your subscription now: https://www.datamintelligence.com/reports-subscription?kb

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Flu Vaccine Market Driven By Public Health Initiatives 2025-2033 | Most Leading Companies - AstraZeneca, Sanofi, CSL, Serum Institute of India Pvt. Ltd, Viatris Inc., Hualan Biological Engineering Inc here

News-ID: 4009521 • Views:

More Releases from DataM Intelligence 4 Market Research LLP

Rheumatoid Arthritis Drugs Market to Reach US$ 56.62 Billion by 2033 at 6.8% CAGR, Driven by Biologic Innovation and Rising Autoimmune Disease Burden | DataM Intelligence
Rheumatoid Arthritis Drugs Market to Reach US$ 56.62 Billion by 2033 at 6.8% CAG …
According to DataM Intelligence, the global rheumatoid arthritis (RA) drugs market reached US$ 31.27 billion in 2024 and is expected to reach US$ 56.62 billion by 2033, growing at a CAGR of 6.8% during the forecast period 2025-2033. Market growth is supported by the rising prevalence of rheumatoid arthritis, increasing adoption of biologics and targeted therapies, early diagnosis, and expanding access to advanced treatment options across developed and emerging healthcare
Antibody-Drug Conjugates Market to Reach US$ 30.42 Billion by 2033 at 11.2% CAGR, Driven by Precision Oncology and Targeted Cancer Therapies | DataM Intelligence
Antibody-Drug Conjugates Market to Reach US$ 30.42 Billion by 2033 at 11.2% CAGR …
According to DataM Intelligence, the global antibody-drug conjugates (ADC) market reached US$ 11.96 billion in 2024 and is expected to reach US$ 30.42 billion by 2033, growing at a CAGR of 11.2% during the forecast period 2025-2033. Market growth is strongly driven by the rising global cancer burden, increasing adoption of targeted oncology therapies, advances in linker and payload technologies, and strong clinical success of next-generation ADCs in solid tumors
Cell Dissociation Market to Reach US$ 915.8 Million by 2033 at 8.7% CAGR; Rising Cell-Based Research and Regenerative Medicine Adoption Drive Growth - Key Players: Thermo Fisher Scientific, Merck, BD
Cell Dissociation Market to Reach US$ 915.8 Million by 2033 at 8.7% CAGR; Rising …
The Global Cell Dissociation Market reached US$ 430.6 million in 2024 and is expected to reach US$ 915.8 million by 2033, growing at a CAGR of 8.7% during the forecast period 2025-2033. The market is expanding steadily due to increasing demand for cell-based research, rising adoption of stem cell and regenerative medicine therapies, and growing investment in biotechnology and pharmaceutical R&D. The surge in cancer research, immunotherapy development, and personalized
Food Waste Management Market to Reach US$ 136.2 Billion by 2032, Driven by Sustainability Mandates and Circular Economy Initiatives | DataM Intelligence
Food Waste Management Market to Reach US$ 136.2 Billion by 2032, Driven by Susta …
According to DataM Intelligence, the global food waste management market reached US$ 69.8 billion in 2024 and is expected to reach US$ 136.2 billion by 2032, growing at a CAGR of 8.7% during the forecast period 2025-2032. Market growth is driven by rising global food waste volumes, stringent environmental regulations, increasing adoption of circular economy models, and growing investments in sustainable waste processing technologies such as anaerobic digestion and recycling.

All 5 Releases


More Releases for Flu

Bird Flu Market Safeguarding Flocks, Securing Health: The Bird Flu Challenge in …
Bird Flu Market to Record an Exponential CAGR by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Bird Flu Market - (By Virus Type (H5N1, H7N9, H5N6, H5N8, H10N8, H9N2, Others), By Test Type (PCR Tests, ELISA Tests, Hemagglutination Assays, Virus Isolation Tests, Next Generation Sequencing, Others), By Treatment Type (Vaccines, Antiviral Medication, Immunomodulators, Others),
Microneedle Flu Vaccine Market New develop microneedle patch for flu vaccination
Drug delivery through the skin by transdermal patches has always been effective against viral infection and flu. Drug delivery through transdermal route is mainly effective due to passive diffusion of the drug and followed by drug development in transdermal delivery systems through different mechanism of action such as iontophorresis and sonophoresis. Moreover, pharmaceutical companies are focusing on development of micro-needle vaccines due to its immense utility in transdermal delivery of
Flu Vaccine (Influenza Vaccine) Market: A look into the future of the “Univers …
Latest update on Flu Vaccine (Influenza Vaccine) Market Analysis Report published with an SMI, the industry growth analysis, and Projection by 2021-2028. This report is highly predictive as it holds the overall market analysis of the topmost companies in the Flu Vaccine (Influenza Vaccine) industry. With the classified Flu Vaccine (Influenza Vaccine) market research based on various growing regions, this report provides leading players' portfolios along with sales, growth, market
Researchers Develop Microneedle Flu Vaccine for flu vaccination
New research funding to develop commercially available micro needle flu vaccine, which would pace up the launch of these products. In 2015, the Georgia Institute of Technology and Micron Biomedical were awarded US$ 2.5 million in grants from the Bill & Melinda Gates Foundation to advance the development of dissolvable microneedle patches for polio immunization. This would also widen up the disease profile for which microneedle vaccine could be developed. Growing
Canine Flu Therapeutics Market 2019| To Develop Therapeutics For The Flu To Cont …
"Canine Flu Therapeutics Market: Global Industry Analysis 2013-2017 and Opportunity Assessment 2018-2028" is the latest addition to MarketResearchReports.Biz industry research reports collection. Canine flu (also known as dog flu) is a contagious respiratory disease in dogs mainly caused by Type A influenza/canine influenza virus. They are two various kinds of influenza viruses namely H3N8 virus and H3N2. Canine flu originated in horses, spread to dogs, and now spreads in between dogs
Sunshine vitamin prevents flu
The vitamin D supply is one of the key factors for the outbreak and the course of influenza epidemics. Norwegian scientists have drawn this conclusion from a study on influenza epidemics, which has now been published in the specialist journal “International Journal of Infectious Diseases”. According to this study, with these influenza epidemics the infection and mortality rates increase with decreasing exposure to sunlight and thus, with decreasing vitamin D